Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma
Maryam Safari, Luigi Scotto, Agnès Basseville, Thomas Litman, Haoran Xue, Lubov Petrukhin, Ping Zhou, Helen Elaine Remotti, Amy W. Ku, Diana V. Morales, Christopher B. Damoci, Mingzhao Zhu, Ravikanth Maddipati, Kenneth G. Hull, Robert W. Robey, , Susan Elaine Bates
This paper shows that combining HDAC and eIF4A inhibitors effectively treats pancreatic cancer by inducing epigenetic reprogramming and metabolic stress in preclinical models.
Drug Resistance Updates · Oct 5, 2025Peer-reviewedCancer Biology